These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1626101)

  • 1. [The cytosolic concentrations of CAM26 and CAM29 in breast tumors classified according to the clinical stage].
    Fernández M; Suárez B; González C; Allende MT
    Rev Clin Esp; 1992 May; 190(9):480-1. PubMed ID: 1626101
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytosol concentrations of CAM29 in breast carcinoma. Effect of the pS2].
    Suárez B; Fernández Llana B; Allende MT; Ruibal A
    Rev Clin Esp; 1992 Oct; 191(5):284. PubMed ID: 1475450
    [No Abstract]   [Full Text] [Related]  

  • 3. BCM-IMx and CA15.3 serum levels in patients with breast cancer: a comparative study.
    Allende MT; Fernández Llana B; Rodriguez Alvarez JM; Roiz MC; Vizoso F; Ruibal A
    Bull Cancer; 1991; 78(8):743-5. PubMed ID: 1932840
    [No Abstract]   [Full Text] [Related]  

  • 4. CAM26 and CAM29 cytosol levels in breast tumors classified according to estrogen receptor status. First results.
    Suarez B; González C; Allende MT; Fernández Fernández M; Fernández Llana B; Roiz MC; Vizoso F; Ruibal A
    Int J Biol Markers; 1992; 7(2):126-8. PubMed ID: 1634825
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mucoid carcinoma antigen--a new tumor marker].
    Bieglmayer C; Szepesi T; Neunteufel W
    Gynakol Rundsch; 1988; 28 Suppl 2():203-5. PubMed ID: 3234919
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of tumor marker CA15-3 in breast cancer].
    Kikuchi K; Uematsu Y; Takada Y; Kurihara E; Suito T; Fujisaki M; Takahashi R; Tamura T
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3095-100. PubMed ID: 3479052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Place of carbohydrate antigens in the spectrum of protein tumor markers in patients with tumors at different sites].
    Reznikov IuP; Ul'ianov VI; Variukhin AS; Vanin AI; Vorontsova LP
    Vopr Onkol; 1988; 34(1):51-6. PubMed ID: 3422524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of tumor markers in breast cancer patients].
    Ito T; Tanaka S; Ban K; Sakai N; Oshita H; Oiwa T; Kanno A; Kashizuka T
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2917-23. PubMed ID: 3310907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of monoclonal antibody-based immunoassays: breast carcinoma-associated mucins as tumor markers.
    Brown JP; Linsley PS; Horn D
    Immunol Ser; 1990; 53():69-82. PubMed ID: 1713071
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative immunohistochemical studies of the histopathology of the breast using monoclonal antibodies Lu-5 and b-12].
    Förster C; Bässler R
    Pathologe; 1991 Mar; 12(2):60-5. PubMed ID: 1711692
    [No Abstract]   [Full Text] [Related]  

  • 11. [What did tumor markers bring us?].
    Seitzer D
    Zentralbl Gynakol; 1991; 113(7):389-96. PubMed ID: 2063633
    [No Abstract]   [Full Text] [Related]  

  • 12. Simple mucins (T, sialosyl-T, Tn and sialosyl-Tn) are not diagnostic for malignant breast lesions.
    Reed W; Bryne M; Clausen H; Dabelsteen E; Nesland JM
    Anticancer Res; 1994; 14(2B):609-15. PubMed ID: 7516636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
    Bray KR; Koda JE; Gaur PK
    Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of CA15-3 in human breast cancer].
    Nihei M; Nomizu T; Tsuchiya A; Abe R
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):987-95. PubMed ID: 3480326
    [No Abstract]   [Full Text] [Related]  

  • 15. [Carcinoma of the ovary: reliability of its markers].
    Moggian G; Gunelli R; Magrone F; Canali P; Spadazzi AP; Pini PL
    Minerva Ginecol; 1988 Jan; 40(1):9-13. PubMed ID: 3163780
    [No Abstract]   [Full Text] [Related]  

  • 16. Serological tumor markers for monitoring breast cancer.
    Sölétormos G
    Dan Med Bull; 2001 Nov; 48(4):229-55. PubMed ID: 11767127
    [No Abstract]   [Full Text] [Related]  

  • 17. Mucin glycoproteins as tumor markers.
    Feller WF; Henslee JG; Kinders RJ; Manderino GL; Tomita JT; Rittenhouse HG
    Immunol Ser; 1990; 53():631-72. PubMed ID: 2100576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of serum concentrations of BCM and MCA, CA 549 and CA 15.3 in women with macrocystic disease of breast].
    Vizoso F; Roiz MC; Allende MT; Ruibal A
    Med Clin (Barc); 1990 Mar; 94(8):319. PubMed ID: 2342398
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunohistochemical tumor diagnosis in breast cancer--use for assessing the stage and biology of so-called "small breast cancer"].
    Schauer A; Rothe H; Balzer I; Fiebig I; Rauschecker H
    Rontgenblatter; 1988 Aug; 41(8):340-4. PubMed ID: 3064267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor markers in human breast cancer].
    Takami H; Shikata J
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):2998-3003. PubMed ID: 3479050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.